Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00042536 · ClinicalTrials.gov registry record
Effects of Yohimbine and Naltrexone on Sexual Function
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 40
- Enrollment target
NCT00042536 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 40 participants.
The verdict
NCT00042536 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the drugs yohimbine and naltrexone in treating men with erectile dysfunction (ED) (the inability to achieve or maintain penile erection for satisfactory sexual performance). ED is a medical and psychological problem that is usually associated with increased age. Evidence suggests that specific neurotransmitter systems are involved in the regulation of sexual function. Yohimbine and naltrexone are drugs that may influence these neurotransmitter systems. This study will use different doses of yohimbine and fixed doses of naltrexone to determine their effectiveness in treating ED. Participants in this study will be screened with a medical history, physical examination, blood and urine tests, and an electrocardiogram (ECG). The study will consist of three outpatient visists.
Interventions
- DRUG Naltrexone HCL/ Yohimbine HCL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2002-07 |
| Est. Completion | 2004-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00042536
The ClinicalTrials.gov registry entry for NCT00042536 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naltrexone HCL/ Yohimbine HCL is the first listed.
NCT00042536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00042536 about?
NCT00042536 is a clinical study titled "Effects of Yohimbine and Naltrexone on Sexual Function". The purpose of this study is to evaluate the safety and effectiveness of the drugs yohimbine and naltrexone in treating men with erectile dysfunction (ED) (the inability to achieve or maintain penile erection for satisfactory sexual performance). ED is a medical and psychological problem that is us...
What is the current status of trial NCT00042536?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2002-07. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00042536?
The interventions under investigation include: Naltrexone HCL/ Yohimbine HCL (DRUG).
Who is sponsoring clinical trial NCT00042536?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.